Monsanto Seeks Buyer for Controversial Milk-Boosting Drug

Monsanto disclosed today that it is looking for a buyer for its bovine milk boosting drug Posilac recombinant bovine somatotropin (rBST). Monsanto did not disclose if it was yet in talks with a prospective buyer or how much it is seeking for the business.   Monsanto says product safety concerns among some dairy farming groups about the product are not the reason for the planned sale of the business, which company says is a "really great" product. “We believe repositioning the business with a strategic owner will allow Monsanto to...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers